Targeting vascular endothelial growth factor in patients with squamous cell lung cancer

J Clin Oncol. 2012 Apr 1;30(10):1137-9. doi: 10.1200/JCO.2011.40.4053. Epub 2012 Feb 21.
No abstract available

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma of Lung
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Squamous Cell / blood supply
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Gene Expression Regulation, Neoplastic
  • Hemorrhage / chemically induced
  • Humans
  • Lung Neoplasms / blood supply
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Receptors, Vascular Endothelial Growth Factor / drug effects
  • Receptors, Vascular Endothelial Growth Factor / metabolism*
  • Signal Transduction / drug effects*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / drug effects
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • Vascular Endothelial Growth Factor Receptor-3 / metabolism

Substances

  • Angiogenesis Inhibitors
  • Biomarkers, Tumor
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-3